Shionogi & Co Ltd 2025 SR
The report outlines the SHIONOGI Group's environmental initiatives and performance for the fiscal year ended March 31, 2025. Key highlights include the Kanegasaki Plant becoming the first facility in Japan to obtain the BSI Kitemark™ for Minimized Risk of AMR certification for its antibiotic manufacturing processes. The company also achieved a 23.3% reduction in Scope 1 and 2 greenhouse gas emissions compared to the FY2019 benchmark, exceeding its annual target. Additionally, SHIONOGI expanded its renewable energy electricity introduction rate to 55.8% and launched a collaborative ointment container recycling program in Osaka.
Company: Shionogi & Co Ltd
Sector: Health Care
Country: Japan
Year: 2025
Type: SR
Pages: 82
Shionogi & Co Ltd
Environment Report
The report outlines the SHIONOGI Group's environmental initiatives and performance for the fiscal year ended March 31, 2025. Key highlights include the Kanegasaki Plant becoming the first facility in Japan to obtain the BSI Kitemark™ for Minimized Risk of AMR certification for its antibiotic manufacturing processes. The company also achieved a 23.3% reduction in Scope 1 and 2 greenhouse gas emissions compared to the FY2019 benchmark, exceeding its annual target. Additionally, SHIONOGI expanded its renewable energy electricity introduction rate to 55.8% and launched a collaborative ointment container recycling program in Osaka.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Net Zero Target
Employees